Lv5
1250 积分 2025-02-18 加入
IL-9 signaling redirects CAR T cell fate toward CD8+ memory and CD4+ cycling states, enhancing antitumor efficacy
1个月前
已完结
Agonistic anti-CD40 antibody treatment converts resident regulatory T cells into activated type 1 effectors within the tumor microenvironment
1个月前
已完结
Targeting cholesterol esterification sensitizes liver cancer to CD8+ T cell attack by impairing metabolic and redox resilience
1个月前
已完结
Lactate binds and inhibits the innate immune sensor STING to promote tumor immune evasion
1个月前
已完结
MEK-dependent bioenergetic demand drives terminal CD8+ T cell exhaustion
1个月前
已完结
A Novel GUCY2C-CD3 T-Cell Engaging Bispecific Construct (PF-07062119) for the Treatment of Gastrointestinal Cancers
3个月前
已完结
One Pivotal Trial, the New Default Option for FDA Approval - Ending the Two-Trial Dogma
6个月前
已完结
CAR-T cell therapy for hepatocellular carcinoma: current trends and challenges
6个月前
已完结
Novel GPC3 N-terminal bispecific antibody exhibits dual anti-tumor effect against tumor cells
6个月前
已完结
Expression of human T cell receptor-gamma delta structural forms
6个月前
已完结
皖公网安备34019202002308
